Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Provenge extends prostate cancer survival by about 4 months.

Targeting EGFR may help reduce hair loss from chemotherapy.

Finasteride may help treat childhood brain tumors by activating certain genes.

CXCR2 in skin cells promotes tumor growth.

E6/E7 oncogenes in hair follicles cause continuous hair growth by skipping the resting phase.

Radiotherapy affects mitochondrial-related genes in metastatic breast cancer cells.

The type of tumor suppressor gene lost affects the behavior of skin cancer.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

4-octyl itaconate may prevent hearing loss caused by the drug cisplatin by activating certain cell protection pathways.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

Pygo2 is important for early growth and progression of intestinal tumors, and could be a target for treating cancers with certain mutations.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Cancer prevention has advanced significantly, with some strategies proving successful.

The PML protein helps prevent skin cancer in mice.

Suppressing ODC activity reduces tumor growth in hair follicles.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.